Actinium Pharmaceuticals Inc (ATNM) — Capital Reinvestment Ratio
Actinium Pharmaceuticals Inc (ATNM) has a Capital Reinvestment Ratio of 0.01x as of June 2022, meaning it reinvests 0% of its operating cash flow ($27.92 Million) in capital expenditures ($270.00K). See ATNM equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Actinium Pharmaceuticals Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Actinium Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Check ATNM total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Actinium Pharmaceuticals Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Actinium Pharmaceuticals Inc from 2022 to 2022. For live market cap and broader valuation context, see ATNM market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.04x | $8.64 Million | $366.00K | — |